Anticipating and treating opioidassociated adverse effects
| Autor: | Amy J Cunningham, Kenneth C. Jackson, Edwin D Dunteman, Christopher M. Herndon, Donna Kalauokalani |
|---|---|
| Rok vydání: | 2003 |
| Předmět: |
Drug
medicine.medical_specialty Substance-Related Disorders Nausea media_common.quotation_subject Pain medicine Humans Endocrine system Pharmacology (medical) Intensive care medicine Adverse effect media_common business.industry Disease Management General Medicine Analgesics Opioid Chronic disease Opioid Anesthesia Chronic Disease medicine.symptom Opiate business Substance abuse disorder medicine.drug |
| Zdroj: | Expert Opinion on Drug Safety. 2:305-319 |
| ISSN: | 1744-764X 1474-0338 |
| Popis: | Opioids are frequently avoided as viable tools in the management of pain due to perceived dangerous or untoward adverse drug events. Whilst they are relatively safe options for the treatment of pain, side effects and toxicities do exist and should be anticipated by the provider. The central nervous, gastrointestinal, genito-urinary, integumentary, metabolic/endocrine, cardiovascular, pulmonary, hepatic/renal, ocular and immune systems all manifest changes associated with opioid therapy. These adverse events, ranging from nuisance to therapy-limiting, are manageable when addressed quickly and appropriately. Opioids are safe and efficacious analgesics when these effects are considered. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|